[ACRS] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -32.77%
YoY- -59.77%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 1,407 1,095 983 5,865 5,041 3,669 1,628 -9.26%
PBT -15,328 -19,177 -23,138 -49,876 -37,565 -38,551 -32,740 -39.67%
Tax -318 -32,181 32,733 18,504 0 -958 0 -
NP -15,586 -18,594 -55,319 -49,876 -37,565 -38,551 -32,740 -39.00%
Tax Rate - - - - - - - -
Total Cost 16,993 19,689 56,302 55,741 42,606 42,220 34,368 -37.44%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -1,107.75 -1,698.08 -5,627.57 -850.40 -745.19 -1,050.72 -2,011.06 -32.77%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -0.37 -0.45 -1.34 -1.21 -0.91 -0.99 -1.06 -50.39%
EPS Diluted -0.37 -0.45 -1.34 -1.21 -0.91 -0.99 -1.06 -50.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.